CD40LG and Miyoshi myopathy: While MGRS treatment regimens are usually extrapolated from MM and other indolent B-cell LPD, the choice of treatment for MGRS occurring with an IgM paraprotein would usually necessitate targeting a lymphoplasmacytic rather than a plasma cell clone (37).